RANI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Rani Therapeutics Holdings Inc (RANI) is not a strong buy for a beginner, long-term investor at this time. While the technical indicators show some positive momentum, the lack of significant financial growth, weak trading trends, and absence of positive catalysts make this stock less appealing for a long-term investment strategy.
The MACD is positive and expanding (0.0151), indicating bullish momentum. RSI is neutral at 62.729, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level (R1: 1.381) with a pre-market price of 1.33.
NULL identified. No recent news or significant insider/hedge fund activity.
The company's financials show declining net income (-20.21% YoY) and EPS (-50.00% YoY). No significant trading trends from insiders or hedge funds. Congress trading data is also absent.
In Q3 2025, revenue remained at 0 with no YoY growth. Net income dropped to -$5.41M (-20.21% YoY), and EPS fell to -0.12 (-50.00% YoY). Gross margin remained at 100%, but the lack of revenue growth and increasing losses indicate poor financial health.
No data on analyst ratings or price target changes is available for this stock.
